Open Access

Cardiorenal benefits of finerenone: protecting the heart and kidneys

Event: ESC Congress 2022
Topic: Clinical
Session type: Satellite Symposium
Sponsored by Bayer
Date: 28 August 2022
Time: 12:45 - 13:45

Congress Session

5 presentations in this session

Welcome and introductions.

Speaker: Professor G. Filippatos (Athens, GR)
Speaker: Professor G. Bakris (Chicago, US)
Thumbnail

Cardiovascular protection in patients with chronic kidney disease (CKD) and T2D: time for a new approach?

Speaker: Professor J. Bauersachs (Hannover, DE)
Thumbnail

Finerenone use in CKD and T2D: from clinical trials to the clinic.

Speaker: Doctor P. Taub (San Diego, US)
Speaker: Professor G. Bakris (Chicago, US)
Thumbnail

Finerenone in cardiovascular care: exploring a new treatment pathway.

Speaker: Professor A. Voors (Groningen, NL)
Thumbnail

Q&A and close.

Thumbnail

6 speakers from this session

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
55 presentations
4 followers

Professor George Bakris

University of Chicago Medicine, Chicago (United States of America)
3 presentations
1 follower

Professor Johann Bauersachs

Hannover Medical School, Hannover (Germany)
31 presentations
3 followers

Doctor Pam Taub

, San Diego (United States of America)
1 presentation
1 follower

Professor George Bakris

University of Chicago Medicine, Chicago (United States of America)
3 presentations
1 follower

Professor Adriaan Voors

University of Groningen, Groningen (Netherlands (The))
52 presentations
0 follower

This platform is supported by

logo Novo Nordisk